Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$155M |
| 2 |
Amazon
AMZN
|
+$112M |
| 3 |
Illumina
ILMN
|
+$97.7M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$69.6M |
| 5 |
Advanced Micro Devices
AMD
|
+$60.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$419M |
| 2 |
Palantir
PLTR
|
+$188M |
| 3 |
Robinhood
HOOD
|
+$164M |
| 4 |
XYZ
Block Inc
XYZ
|
+$139M |
| 5 |
Unity
U
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.6% |
| 2 | Healthcare | 21.37% |
| 3 | Communication Services | 18.23% |
| 4 | Consumer Discretionary | 15.37% |
| 5 | Financials | 11.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
BILL Holdings
BILL
$4.76B
| $15.1M | 0.13% |
178,565
-2,754
| -2% | -$205K |
|
77
Prime Medicine
PRME
$615M
| $15M | 0.13% |
5,150,233
-510,486
| -9% | -$1.79M |
|
78
3D Systems Corp
DDD
$530M
| $14.5M | 0.12% |
4,413,915
+535,287
| +14% | +$1.71M |
|
79
Intuit
INTU
$100B
| $14.4M | 0.12% |
22,951
-423
| -2% | -$270K |
|
80
Teledyne Technologies
TDY
$29.5B
| $13.9M | 0.12% |
29,887
-599
| -2% | -$279K |
|
81
Veeva Systems
VEEV
$40.3B
| $13.8M | 0.12% |
65,837
-67,916
| -51% | -$14.9M |
|
82
Microsoft
MSFT
$3.59T
| $13M | 0.11% |
30,761
+352
| +1% | +$150K |
|
83
Synopsys
SNPS
$76.2B
| $12.7M | 0.11% |
26,213
-138
| -0.5% | -$72.1K |
|
|
ANSS
84
DELISTED
Ansys
ANSS
| $12.3M | 0.1% |
36,450
-1,635
| -4% | -$548K |
|
|
P
85
Everpure Inc
P
$36.1B
| $12.3M | 0.1% |
200,149
+4,976
| +3% | +$277K |
|
86
Ibotta
IBTA
$760M
| $11.5M | 0.1% |
176,161
+94,522
| +116% | +$6.56M |
|
87
L3Harris
LHX
$49.7B
| $11.4M | 0.1% |
54,401
-4,954
| -8% | -$1.19M |
|
88
Incyte
INCY
$25.9B
| $11.2M | 0.09% |
161,775
-49,761
| -24% | -$3.55M |
|
89
Zillow
Z
$8.07B
| $11.1M | 0.09% |
150,130
-2,304
| -2% | -$165K |
|
|
AVDX
90
DELISTED
AvidXchange
AVDX
| $10.8M | 0.09% |
1,044,806
-117,192
| -10% | -$1.14M |
|
91
Lockheed Martin
LMT
$130B
| $10.7M | 0.09% |
22,013
-1,288
| -6% | -$702K |
|
92
BWX Technologies
BWXT
$14.4B
| $10.6M | 0.09% |
+94,923
| New | +$11.6M |
|
93
Vertex Pharmaceuticals
VRTX
$139B
| $10.2M | 0.09% |
25,350
-25,749
| -50% | -$11.9M |
|
94
Cameco
CCJ
$44.6B
| $10.2M | 0.08% |
198,015
-7,218
| -4% | -$393K |
|
95
Intuitive Surgical
ISRG
$134B
| $10.2M | 0.08% |
19,450
-354
| -2% | -$184K |
|
96
Intercontinental Exchange
ICE
$90.5B
| $9.97M | 0.08% |
66,923
-1,026
| -2% | -$163K |
|
|
OKLO
97
Oklo
OKLO
$7.83B
| $9.64M | 0.08% |
454,294
-573,708
| -56% | -$11.1M |
|
98
Regeneron Pharmaceuticals
REGN
$85.9B
| $9.4M | 0.08% |
13,192
-1,959
| -13% | -$1.64M |
|
99
Xometry
XMTR
$4.79B
| $7.74M | 0.06% |
181,478
-102,656
| -36% | -$2.9M |
|
100
Caterpillar
CAT
$381B
| $7.57M | 0.06% |
20,856
-756
| -3% | -$293K |
|
Similar funds
Cathie Wood's Q4 2024 Portfolio in Review
As of Q4 2024, Cathie Wood held 194 positions worth $12B, up 9.8% from $10.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Cathie Wood withdrew a net $862M in Q4 2024, closing 11 positions and reducing 123 holdings. Its most notable exit was Moderna, an estimated $77.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Cathie Wood opened a new position in Illumina worth $91.7M.
- Cathie Wood's largest Q4 2024 buy was Illumina: 686,330 shares worth $91.7M.
- Cathie Wood added most to Tempus AI in Q4 2024, an estimated $155M increase.
- Cathie Wood's biggest Q4 2024 reduction was Tesla, cutting an estimated $419M.
- Cathie Wood fully exited Moderna in Q4 2024, selling an estimated $77.8M.
- Cathie Wood's ten largest holdings make up 51% of its $12B portfolio in Q4 2024.
- Cathie Wood opened 7 new positions and closed 11 in Q4 2024.
- Cathie Wood's portfolio value rose 9.8% quarter-over-quarter to $12B.
Based on ARK Investment Management's 13F filing for Q4 2024, filed 4 Feb 2025.